| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000014089 |
| Receipt No. | R000016404 |
| Official scientific title of the study | Neo-Adjuvant Chemotherapy plus nephroureterectomy in Kyoto University |
| Date of disclosure of the study information | 2014/05/27 |
| Last modified on | 2018/05/30 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Neo-Adjuvant Chemotherapy plus nephroureterectomy in Kyoto University | |
| Title of the study (Brief title) | NACNUK trial | |
| Region |
|
|
| Condition | ||
| Condition | urothelial carcinoma of upper urinary tract | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the efficacy and safety of neoadjuvant chemotherapy with gemcitabine/CDDP or gemcitabine/CBDCA before radical nephroureterectomy against locally advanced urothelial carcinoma of upper urinary tract |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | 3-year disease-free survival rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | neoadjuvant chemotherapy plus radical nephroureterectomy | |
| Interventions/Control_2 | radical nephroureterectomy | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 clinical diagonosis of invasive urothelial carcinoma of upper urinary tract (cT2-4 or cTxN+) by imaging and urinary cytology
2 cases without unresectable distant metastasis 3 cases that an radical operation under the general anesthesia is possible. 4 cases with primary urothelial carcinoma (cases with hirtory of non-muscle invasive bladder cancer can be registered.) 5 Performance status 0-1 6 Cases maintaining the functions of the main organs. |
|||
| Key exclusion criteria | 1 Pregnant or potentially women, nursing women
2 Patients with past history of radicalcystectomy 3 Patients with psychiatric diseases 4 Patients with severe or complicated medical conditions, not allowing participation into this protocol |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Osamu Ogawa |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | the Department of Urology |
| Address | Kawahara-cho 54, Shogoin, Sakyo-ku, Kyoto, Japan |
| TEL | 075-751-3325 |
| ogawao@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Yoshiyuki Matsui |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | the Department of Urology |
| Address | Kawahara-cho 54, Shogoin, Sakyo-ku, Kyoto, Japan |
| TEL | 075-751-3337 |
| Homepage URL | |
| ym1108@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | the Department of Urology, Graduate School of Medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | the Department of Urology, Graduate School of Medicine, Kyoto University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016404 |